Search for a command to run...
No recent news available for this stock.
Conference call summary is not available for this stock.
Venus Remedies Ltd. presents a competitive valuation and solid growth metrics compared to its peers in the pharmaceuticals sector. While it has the lowest PE ratio along with strong cash flow metrics, some peers exhibit better profitability and growth. Companies like Mankind Pharma and Dr. Reddy's demonstrate superior growth, while Divi's Laboratories stands out for its profitability despite a high PE ratio.
Best profitability with high ROE and strong growth metrics.
Highest revenue growth YoY and over the past three years, showcasing strong market performance.
Solid profitability metrics and reasonable valuation ratios.